Maurizio Fava, MD

Article

Ketamine for Suicidal Ideation

June 22, 2016

When your treatment-resistant depressed patients are thinking about suicide, what else can you as a clinician do to pull them from the brink of these ideations? Consider whether adjunctive...

Dawn F. Ionescu, Michaela B. Swee, Kara J. Pavone, et al

Original Research

Long-Term Efficacy, Safety, and Tolerability of l-Methylfolate Calcium 15 mg as Adjunctive Therapy With Selective Serotonin Reuptake Inhibitors: A 12-Month, Open-Label Study Following a Placebo-Controlled #05#

May 25, 2016

John M. Zajecka, Maurizio Fava, Richard C. Shelton, et al

Meta-Analysis

Monotherapy in Mood Disorders

May 25, 2016

Is one drug good enough? Read this review of 215 double-blind, randomized, placebo-controlled trials to discover which monotherapies have overall short-term efficacy in treating MDD and bipolar depression.

George I. Papakostas, Max A. Martinson, Maurizio Fava, et al

Original Research

Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants: A Randomized, Double-Blind, Placebo-Controlled Study in Adult Patients With Major Depressive Disorder

March 23, 2016

Suresh Durgam, Willie Earley, Hua Guo, et al

Original Research

Association of Obesity and Inflammatory Marker Levels on Treatment Outcome: Results From a Double-Blind, Randomized Study of Adjuncve L-Methylfolate Calciumin Paents With MDD Who Are Inadequate Responders to SSRIs

December 23, 2015

Richard C. Shelton, Michael J. Pencina, Lori W. Barrentine, et al

Article

Prevalence and Impact of Obsessive-Compulsive Symptoms in Depression: A STAR*D Report

December 23, 2015

Lee Baer, Madhukar H. Trivedi, Ilana Huz, et al

Article

A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders

April 16, 2015

In this naturalistic study, Brennan and colleagues evaluated the use of a commercially available genetic test—the Genecept Assay—to help guide clinician treatment decisions to improve outcomes for psychiatric patients.Â

Francis X. Brennan, Kathryn R. Gardner, Jay Lombard, et al

Letter to the Editor

Dr Mischoulon and Colleagues Reply

November 24, 2014

David Mischoulon, Lawrence H. Price, Linda L. Carpenter, et al

Commentary

Depression: Addressing Partial Response After First-Line Antidepressant Treatment

September 25, 2014

Michael E. Thase, Maurizio Fava, Andrew A. Nierenberg

Original Research

Effect of Adjunctive l-Methylfolate 15 mg Among Inadequate Responders to SSRIs in Depressed Patients Who Were Stratified by Biomarker Levels and Genotype: Results From a Randomized Clinical Trial

April 15, 2014

George I. Papakostas, Richard C. Shelton, John M. Zajecka, et al

ASCP Corner

The ASCP Annual Meeting (NCDEU): A History

February 15, 2014

Maurizio Fava

Educational Activity

Assessing Response to Treatment and Recognizing Residual Depressive Symptoms

January 15, 2014

Maurizio Fava

Ketamine for Suicidal Ideation

Long-Term Efficacy, Safety, and Tolerability of l-Methylfolate Calcium 15 mg as Adjunctive Therapy With Selective Serotonin Reuptake Inhibitors: A 12-Month, Open-Label Study Following a Placebo-Controlled #05#

Monotherapy in Mood Disorders

Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants: A Randomized, Double-Blind, Placebo-Controlled Study in Adult Patients With Major Depressive Disorder

Association of Obesity and Inflammatory Marker Levels on Treatment Outcome: Results From a Double-Blind, Randomized Study of Adjuncve L-Methylfolate Calciumin Paents With MDD Who Are Inadequate Responders to SSRIs

Prevalence and Impact of Obsessive-Compulsive Symptoms in Depression: A STAR*D Report

A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders

Dr Mischoulon and Colleagues Reply

Depression: Addressing Partial Response After First-Line Antidepressant Treatment

Effect of Adjunctive l-Methylfolate 15 mg Among Inadequate Responders to SSRIs in Depressed Patients Who Were Stratified by Biomarker Levels and Genotype: Results From a Randomized Clinical Trial

The ASCP Annual Meeting (NCDEU): A History

Assessing Response to Treatment and Recognizing Residual Depressive Symptoms

ELSEWHERE:

FOLLOW US:

Maurizio Fava, MD

Ketamine for Suicidal Ideation

Long-Term Efficacy, Safety, and Tolerability of l-Methylfolate Calcium 15 mg as Adjunctive Therapy With Selective Serotonin Reuptake Inhibitors: A 12-Month, Open-Label Study Following a Placebo-Controlled #05#

Monotherapy in Mood Disorders

Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants: A Randomized, Double-Blind, Placebo-Controlled Study in Adult Patients With Major Depressive Disorder

Association of Obesity and Inflammatory Marker Levels on Treatment Outcome: Results From a Double-Blind, Randomized Study of Adjuncve L-Methylfolate Calciumin Paents With MDD Who Are Inadequate Responders to SSRIs

Prevalence and Impact of Obsessive-Compulsive Symptoms in Depression: A STAR*D Report

A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders

Dr Mischoulon and Colleagues Reply

Depression: Addressing Partial Response After First-Line Antidepressant Treatment

Effect of Adjunctive l-Methylfolate 15 mg Among Inadequate Responders to SSRIs in Depressed Patients Who Were Stratified by Biomarker Levels and Genotype: Results From a Randomized Clinical Trial

The ASCP Annual Meeting (NCDEU): A History

Assessing Response to Treatment and Recognizing Residual Depressive Symptoms

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles